Evidence map›Paper›PMID 31941872›Full record

ArticleInternal medicine (Tokyo, Japan)2020

A Radical Approach to Acute Lymphoblastic Leukemia Treatment: A Case Study of a Veterinarian Specializing in Livestock who Developed Disseminated Mucormycosis during Induction Therapy.

Toshiro Sakai, Ken Sato, Tomoki Kikuchi, Masahiko Obata, Yuichi Konuma

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives.Asian Pacific journal of cancer prevention : APJCP · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Toshiro SakaiDepartment of Hematology and Oncology, Asahikawa Red Cross Hospital, Japan.
Ken SatoDepartment of Hematology and Oncology, Asahikawa Red Cross Hospital, Japan.
Tomoki KikuchiDepartment of Hematology and Oncology, Asahikawa Red Cross Hospital, Japan.
Masahiko ObataDepartment of Hematology and Oncology, Asahikawa Red Cross Hospital, Japan.
Yuichi KonumaDepartment of Hematology and Oncology, Asahikawa Red Cross Hospital, Japan.
Japanese Red Cross Asahikawa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucormycosis has emerged as the third-most common fungal mycosis and is one of the most fatal molds. We herein report a case study of a 30-year-old woman who was a veterinarian, specializing in livestock, who developed disseminated mucormycosis during induction therapy for acute lymphoblastic leukemia. We successfully used a radical approach for treatment, including a surgical procedure and allogeneic transplantation, with continuous administration of antifungal agents. Reports of successful treatments are extremely rare, and our case has had the longest documented remission from disseminated disease. We speculate that our case's occupational environment may represent a risk factor for development of mucormycosis.

Indexed as

VeterinariansAcute DiseaseAdultAgricultural Workers' DiseasesAnimalsAntifungal AgentsHematopoietic Stem Cell TransplantationHumansImmunocompromised HostLivestockMaleMucormycosisOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, HomologousTreatment OutcomeAntifungal Agentsdairy workersdisseminated diseasehematopoietic stem cell transplantationmucormycosis

Identifiers

PMID31941872
PMCPMC7008056
OpenAlexW2999707044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.